Literature DB >> 2495962

Fatal graft versus host disease after platelet transfusions in a child with purine nucleoside phosphorylase deficiency.

S Strobel1, G Morgan, A H Simmonds, R J Levinsky.   

Abstract

Fatal graft versus host disease (GVHD) developed in a child with purine nucleoside phosphorylase (PNP) deficiency following an unirradiated platelet transfusion. IV treatment with an anti-T-cell monoclonal antibody (CD7) led to a transient improvement of his GVHD (Grade IV) but did not prevent the fatal outcome. This report emphasizes the need for blood products to be irradiated when cell mediated immunodeficiency is suspected, even in patients with residual immunocompetence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495962     DOI: 10.1007/bf00444121

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

Review 1.  Post-transfusion graft-vs-host disease (GVHD): immunopathology and prevention.

Authors:  E Fagiolo; A M D'Addosio
Journal:  Haematologica       Date:  1985 Jan-Feb       Impact factor: 9.941

2.  Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.

Authors:  H Waldmann; S Cobbold; A Wilson; M Clark; S Watt; G Hale; H Tighe
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

3.  Chronic graft-versus-host disease after blood transfusions confirmed by incompatible HLA antigens in bone marrow.

Authors:  M A Siimes; S Koskimies
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

4.  Thymic involution mimicking thymic dysplasia: a consequence of transfusion-induced graft versus host disease in a premature infant.

Authors:  T A Seemayer; R P Bolande
Journal:  Arch Pathol Lab Med       Date:  1980-03       Impact factor: 5.534

5.  Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

Authors:  R Parkman; D Mosier; I Umansky; W Cochran; C B Carpenter; F S Rosen
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

6.  Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.

Authors:  R E Dinsmore; D J Straus; M S Pollack; J M Woodruff; T J Garrett; C W Young; B D Clarkson; B Dupont
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

7.  Graft-versus-host reaction following blood product transfusion.

Authors:  V von Fliedner; D J Higby; U Kim
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

8.  Fatal graft versus host disease following a blood transfusion in a child with neuroblastoma.

Authors:  W G Woods; B H Lubin
Journal:  Pediatrics       Date:  1981-02       Impact factor: 7.124

Review 9.  Human posttransfusion graft-versus-host disease.

Authors:  D B Brubaker
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

10.  Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.

Authors:  R M Lowenthal; L Grossman; J M Goldman; R A Storring; N A Buskard; D S Park; B C Murphy; A S Spiers; D A Galton
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

View more
  2 in total

Review 1.  The immunocompromised patient and transfusion.

Authors:  K G Badami
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

Authors:  M R Aust; L G Andrews; M J Barrett; C J Norby-Slycord; M L Markert
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.